UHS logo

Universal Health Services, Inc. Stock Price

NYSE:UHS Community·US$10.2b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 41 Fair Values set on narratives written by author

UHS Share Price Performance

US$171.66
8.18 (5.00%)
US$205.24
Fair Value
US$171.66
8.18 (5.00%)
16.4% undervalued intrinsic discount
US$205.24
Fair Value
Price US$171.66
AnalystConsensusTarget US$205.24
yiannisz US$224.48
AnalystLowTarget US$165.00

UHS Community Narratives

·
Fair Value US$205.24 16.4% undervalued intrinsic discount

Analysts Adjust Fair Value Estimates for Universal Health Services Amid Mixed Outlook and Recent Developments

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
Fair Value
·
Fair Value US$224.48 23.5% undervalued intrinsic discount

Universal Health Services Shows Why Behavioral Healthcare Is Becoming a Core Defensive Growth Sector

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$165 4.0% overvalued intrinsic discount

Lower Medicaid Payments And Rising Costs Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$165
4.0% overvalued intrinsic discount
Revenue
4.85% p.a.
Profit Margin
7.21%
Future PE
7.21x
Price in 2029
US$204.37

Trending Discussion

No trending discussion available.

Updated Narratives

UHS logo

Universal Health Services Shows Why Behavioral Healthcare Is Becoming a Core Defensive Growth Sector

Fair Value: US$224.48 23.5% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
UHS logo

UHS: Lowered 2026 Outlook Will Set Up Rebound In EBITDA

Fair Value: US$250.72 31.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
UHS logo

UHS: Medicaid Policy And Payor Mix Shifts Will Drive Future Upside

Fair Value: US$205.24 16.4% undervalued intrinsic discount
16 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Outstanding track record and undervalued.

2 Risks
3 Rewards

Universal Health Services, Inc. Key Details

US$18.1b

Revenue

US$10.0b

Cost of Revenue

US$8.1b

Gross Profit

US$6.6b

Other Expenses

US$1.5b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
25.21
44.61%
8.42%
63.4%
View Full Analysis

About UHS

Founded
1978
Employees
102000
CEO
Marc Miller
WebsiteView website
uhs.com

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company’s hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Recent UHS News & Updates

Seeking Alpha Jul 29

Universal Health Services: Valuations Look Attractive After A Meaningful Correction

Summary I am initiating coverage on Universal Health Services with a Buy rating and a 24-month investment horizon, citing attractive valuations. UHS’s behavioral health segment offers robust EBITDA margins and geographic diversification, with growth potential from the Talkspace acquisition and UK expansion. Despite concerns from the OBBBA and recent earnings misses, UHS’s strong credit profile, healthy cash flows, and low leverage support continued capital allocation flexibility. UHS trades at a forward EV/EBITDA of 5.72 versus a sector median of 12.78, indicating a meaningful valuation gap and capped downside. Read the full article on Seeking Alpha

Recent updates

No updates